.
Fundamentally strong stock gets a buy call by analyst for an upside of 25%; Do you hold it? 

Fundamentally strong stock gets a buy call by analyst for an upside of 25%; Do you hold it? 

A company is said to be ‘fundamentally strong’ when it portrays a specific set of characteristics, viz, strong and consistent financials, lower leverage ratios, and many more.  Listed below is one such fundamentally strong stock in which HDFC Securities see a potential upside of 25 percent:  Stylam Industries Limited  With a market capitalization of Rs [...]
Ashish Kacholia stocks that delivered multibagger returns up to 320% in a year; Do you hold any? 

Ashish Kacholia stocks that delivered multibagger returns up to 320% in a year; Do you hold any? 

Multibagger stocks are very appealing to investors because they have the potential to multiply your initial investment several times. When identifying possible multi-bagger stocks, factors such as industry strength, debt levels, revenue multiples, PE ratios, and management quality are important considerations.  Here are the three Ashish Kacholia stocks that gave multi-bagger returns in a year.  [...]
How does Tata Technologies differ from Tata Elxsi? Revenue, Clients and Financials explained

How does Tata Technologies differ from Tata Elxsi? Revenue, Clients and Financials explained

TATA Group is one of India's largest conglomerates, comprising 30 companies across ten verticals. The group operates in over 100 countries across six continents.  Tata Sons is the principal investment holding company and promoter of Tata companies. The group imprints are found in a wide range of sectors. As of July 31, 2023, there are [...]
Pharma stock falls by 7% after it received warning letter from USFDA pertaining procedure violations

Pharma stock falls by 7% after it received warning letter from USFDA pertaining procedure violations

The large-cap pharma company's share declined to 7.1 percent Rs 1,175.75 per share from its intraday low on Thursday after the Company announced the warning letter from the US Food and Drug Administration(USFDA).  According to Cipla filing, the US FDA conducted a current good manufacturing practices (cGMP) inspection at Cipla's Pithampur manufacturing facility from February [...]
×